135 related articles for article (PubMed ID: 8703039)
21. Partial reconstitution of photoreceptor cGMP phosphodiesterase characteristics in cGMP phosphodiesterase-5.
Granovsky AE; Artemyev NO
J Biol Chem; 2001 Jun; 276(24):21698-703. PubMed ID: 11285263
[TBL] [Abstract][Full Text] [Related]
22. Molecular determinants of cGMP binding to chicken cone photoreceptor phosphodiesterase.
Huang D; Hinds TR; Martinez SE; Doneanu C; Beavo JA
J Biol Chem; 2004 Nov; 279(46):48143-51. PubMed ID: 15331594
[TBL] [Abstract][Full Text] [Related]
23. Delineation of two functionally distinct gammaPDE binding sites on the bovine retinal cGMP phosphodiesterase by a mutant gammaPDE subunit.
Berger AL; Cerione RA; Erickson JW
Biochemistry; 1999 Jan; 38(4):1293-9. PubMed ID: 9930990
[TBL] [Abstract][Full Text] [Related]
24. The regulation of the cGMP-binding cGMP phosphodiesterase by proteins that are immunologically related to gamma subunit of the photoreceptor cGMP phosphodiesterase.
Lochhead A; Nekrasova E; Arshavsky VY; Pyne NJ
J Biol Chem; 1997 Jul; 272(29):18397-403. PubMed ID: 9218482
[TBL] [Abstract][Full Text] [Related]
25. Characterization of a purified bovine lung cGMP-binding cGMP phosphodiesterase.
Thomas MK; Francis SH; Corbin JD
J Biol Chem; 1990 Sep; 265(25):14964-70. PubMed ID: 1697584
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of transducin activation of frog rod photoreceptor phosphodiesterase. Allosteric interactiona between the inhibitory gamma subunit and the noncatalytic cGMP-binding sites.
Norton AW; D'Amours MR; Grazio HJ; Hebert TL; Cote RH
J Biol Chem; 2000 Dec; 275(49):38611-9. PubMed ID: 10993884
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds.
Turko IV; Ballard SA; Francis SH; Corbin JD
Mol Pharmacol; 1999 Jul; 56(1):124-30. PubMed ID: 10385692
[TBL] [Abstract][Full Text] [Related]
28. Possible stimulation of retinal rod recovery to dark state by cGMP release from a cGMP phosphodiesterase noncatalytic site.
Yamazaki A; Bondarenko VA; Dua S; Yamazaki M; Usukura J; Hayashi F
J Biol Chem; 1996 Dec; 271(51):32495-8. PubMed ID: 8955069
[TBL] [Abstract][Full Text] [Related]
29. Identification of the gamma-subunit interaction sites in the retinal cyclic-GMP phosphodiesterase beta-subunit.
Oppert B; Takemoto DJ
Biochem Biophys Res Commun; 1991 Jul; 178(2):474-9. PubMed ID: 1650192
[TBL] [Abstract][Full Text] [Related]
30. The carboxyl terminus of the gamma-subunit of rod cGMP phosphodiesterase contains distinct sites of interaction with the enzyme catalytic subunits and the alpha-subunit of transducin.
Skiba NP; Artemyev NO; Hamm HE
J Biol Chem; 1995 Jun; 270(22):13210-5. PubMed ID: 7768919
[TBL] [Abstract][Full Text] [Related]
31. Specificity of cGMP binding to a purified cGMP-stimulated phosphodiesterase from bovine adrenal tissue.
Miot F; Van Haastert PJ; Erneux C
Eur J Biochem; 1985 May; 149(1):59-65. PubMed ID: 2581780
[TBL] [Abstract][Full Text] [Related]
32. Comparison of putative cGMP-binding regions in bovine brain and cardiac cGMP-stimulated phosphodiesterases.
Tanaka T; Hockman S; Moos M; Taira M; Meacci E; Murashima S; Manganiello VC
Second Messengers Phosphoproteins; 1991; 13(2-3):87-98. PubMed ID: 1659635
[TBL] [Abstract][Full Text] [Related]
33. Modeling and mutational analysis of the GAF domain of the cGMP-binding, cGMP-specific phosphodiesterase, PDE5.
Sopory S; Balaji S; Srinivasan N; Visweswariah SS
FEBS Lett; 2003 Mar; 539(1-3):161-6. PubMed ID: 12650945
[TBL] [Abstract][Full Text] [Related]
34. Cyclic guanosine 5'-monophosphate binding to regulatory GAF domains of photoreceptor phosphodiesterase.
Cote RH
Methods Mol Biol; 2005; 307():141-54. PubMed ID: 15988061
[TBL] [Abstract][Full Text] [Related]
35. Cyclic GMP-specific, high affinity, noncatalytic binding sites on light-activated phosphodiesterase.
Yamazaki A; Sen I; Bitensky MW; Casnellie JE; Greengard P
J Biol Chem; 1980 Dec; 255(23):11619-24. PubMed ID: 6254976
[TBL] [Abstract][Full Text] [Related]
36. Expression of rat cGMP-binding cGMP-specific phosphodiesterase mRNA in Purkinje cell layers during postnatal neuronal development.
Kotera J; Yanaka N; Fujishige K; Imai Y; Akatsuka H; Ishizuka T; Kawashima K; Omori K
Eur J Biochem; 1997 Oct; 249(2):434-42. PubMed ID: 9370351
[TBL] [Abstract][Full Text] [Related]
37. A new cGMP phosphodiesterase isolated from bovine platelets is substrate for cAMP- and cGMP-dependent protein kinases: evidence for a key role in the process of platelet activation.
Robichon A
J Cell Biochem; 1991 Oct; 47(2):147-57. PubMed ID: 1661738
[TBL] [Abstract][Full Text] [Related]
38. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
Torphy TJ; Zhou HL; Burman M; Huang LB
Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
[TBL] [Abstract][Full Text] [Related]
39. Structural and functional features in human PDE5A1 regulatory domain that provide for allosteric cGMP binding, dimerization, and regulation.
Zoraghi R; Bessay EP; Corbin JD; Francis SH
J Biol Chem; 2005 Mar; 280(12):12051-63. PubMed ID: 15677448
[TBL] [Abstract][Full Text] [Related]
40. A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases.
Zhang KY; Card GL; Suzuki Y; Artis DR; Fong D; Gillette S; Hsieh D; Neiman J; West BL; Zhang C; Milburn MV; Kim SH; Schlessinger J; Bollag G
Mol Cell; 2004 Jul; 15(2):279-86. PubMed ID: 15260978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
